Ignite Creation Date:
2025-12-24 @ 9:54 PM
Ignite Modification Date:
2025-12-25 @ 7:33 PM
Study NCT ID:
NCT01537432
Status:
COMPLETED
Last Update Posted:
2016-01-05
First Post:
2012-02-17
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01
Start Date Type:
None
Primary Completion Date:
2014-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-12
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-17
First Submit QC Date:
None
Study First Post Date:
2012-02-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-12-01
Results First Submit QC Date:
None
Results First Post Date:
2016-01-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-12-01
Last Update Post Date:
2016-01-05
Last Update Post Date Type:
ESTIMATED